Mo1055: COST-EFFECTIVENESS ANALYSIS OF SUBCUTANEOUS INFLIXIMAB FOR INFLAMMATORY BOWEL DISEASES IN SEQUENCIAL BIOLOGICAL TREATMENT

por Baik, Deborah, Atreya, Raja, Bouhnik, Yoram, Casey, Daniel, Jang, Minyoung, Yoon, SangWook, Kwon, Taek S.
Publicado 2022

Activation of JNK and IRE1 is critically involved in tanshinone I-induced p62 dependent autophagy in malignant pleural mesothelioma cells: implication of p62 UBA domain

por Lee, Jihyun, Sohn, Eun Jung, Yoon, Sangwook, Won, Gunho, Kim, Chang Geun, Jung, Ji Hoon, Kim, Sung-Hoon
Publicado 2017

Comparison of Minimally Invasive Versus Open Transforaminal Interbody Lumbar Fusion

por Kim, Chi Heon, Easley, Kirk, Lee, Jun-Seok, Hong, Jae-Young, Virk, Michael, Hsieh, Patrick C., Yoon, Sangwook T.
Publicado 2020

Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial

por D’Haens, Geert, Reinisch, Walter, Schreiber, Stefan, Cummings, Fraser, Irving, Peter M., Ye, Byong Duk, Kim, Dong-Hyeon, Yoon, SangWook, Ben-Horin, Shomron
Publicado 2023

Upregulation of death receptor 5 and activation of caspase 8/3 play a critical role in ergosterol peroxide induced apoptosis in DU 145 prostate cancer cells

por Han, Jonghyun, Sohn, Eun Jung, Kim, Bonglee, Kim, Sunhee, Won, Gunho, Yoon, Sangwook, Lee, Jihyun, Kim, Moon Joon, Lee, Hojin, Chung, Kyujin, Kim, Sung-hoon
Publicado 2014

Trends and Costs of External Electrical Bone Stimulators and Grafting Materials in Anterior Lumbar Interbody Fusion

por D’Oro, Anthony, Buser, Zorica, Brodke, Darrel Scott, Park, Jong-Beom, Yoon, Sangwook Tim, Youssef, Jim Aimen, Meisel, Hans-Joerg, Radcliff, Kristen Emmanuel, Hsieh, Patrick, Wang, Jeffrey Chun
Publicado 2018

Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era

por Schreiber, Stefan, Ben-Horin, Shomron, Alten, Rieke, Westhovens, René, Peyrin-Biroulet, Laurent, Danese, Silvio, Hibi, Toshifumi, Takeuchi, Ken, Magro, Fernando, An, Yoorim, Kim, Dong-Hyeon, Yoon, SangWook, Reinisch, Walter
Publicado 2022

Correction to: Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era

por Schreiber, Stefan, Ben-Horin, Shomron, Alten, Rieke, Westhovens, René, Peyrin-Biroulet, Laurent, Danese, Silvio, Hibi, Toshifumi, Takeuchi, Ken, Magro, Fernando, An, Yoorim, Kim, Dong-Hyeon, Yoon, SangWook, Reinisch, Walter
Publicado 2022

Efficacy of subcutaneous vs intravenous infliximab in rheumatoid arthritis: a post-hoc analysis of a randomized phase III trial

por Constantin, Arnaud, Caporali, Roberto, Edwards, Christopher J, Fonseca, João Eurico, Iannone, Florenzo, Keystone, Edward, Schulze-Koops, Hendrik, Kwon, Taek, Kim, Seungmin, Yoon, SangWook, Kim, Dong-Hyeon, Park, Gahee, Yoo, Dae Hyun
Publicado 2022